FDA Expands Eligibility for COVID-19 Vaccine Boosters

Last Updated: Nov 19, 2021

On Nov. 19, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices will meet later today to discuss further clinical recommendations.

Read More on the FDA website

Login to be able to comment

Leave a comment

ng5136-PA-PAMedSociety-DigitalAd-Brand-970x90